Institutional Ownership Trevi Therapeutics, Inc. (TRVI)
This table provides information about the institutional ownership of Trevi Therapeutics, Inc. (TRVI). We have compiled data on the 114 institutions that hold shares in the stock, with a total of 77.6 Million shares, which have been reported (via 13F filing form) to have a value of $379 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Nea Management Company, LLC
Timonium, MD |
Feb 14, 2025 Q4 2024 |
11,370,376
shares
|
$55.6 Million
3.46% of portfolio
|
Q1 2023
Reduced 0.02%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
10,664,774
shares
|
$52.2 Million
2.72% of portfolio
|
Q4 2024
Added 44.49%
|
|
Viking Global Investors LP
|
Feb 14, 2025 Q4 2024 |
4,400,000
shares
|
$21.5 Million
0.06% of portfolio
|
Q3 2022
New holding
|
|
Rubric Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
4,205,129
shares
|
$20.6 Million
0.3% of portfolio
|
Q4 2024
Reduced 16.35%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
4,150,237
shares
|
$20.3 Million
0.04% of portfolio
|
Q4 2024
New holding
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,509,213
shares
|
$17.2 Million
0.0% of portfolio
|
Q4 2024
Added 7.57%
|
|
Vivo Capital, LLC
Palo Alto, CA |
Feb 13, 2025 Q4 2024 |
3,487,903
shares
|
$17.1 Million
2.9% of portfolio
|
Q4 2024
Added 116.25%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
3,212,597
shares
|
$15.7 Million
0.1% of portfolio
|
Q4 2024
Added 429.93%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,135,115
shares
|
$15.3 Million
0.0% of portfolio
|
Q2 2024
Added 31.97%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
3,094,896
shares
|
$15.1 Million
1.97% of portfolio
|
Q4 2024
Added 101.16%
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
2,906,060
shares
|
$14.2 Million
0.53% of portfolio
|
Q4 2024
New holding
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,500,000
shares
|
$12.2 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
Opaleye Management Inc.
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,317,500
shares
|
$11.3 Million
1.94% of portfolio
|
Q4 2024
Reduced 9.75%
|
|
Acorn Capital Advisors, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
2,001,048
shares
|
$9.79 Million
4.46% of portfolio
|
Q4 2024
New holding
|
|
Mai Capital Management
|
Feb 14, 2025 Q4 2024 |
1,356,886
shares
|
$6.64 Million
0.04% of portfolio
|
Q4 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,299,322
shares
|
$6.35 Million
0.0% of portfolio
|
Q4 2024
Added 2.78%
|
|
Vr Adviser, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,266,457
shares
|
$6.19 Million
0.89% of portfolio
|
Q4 2024
Reduced 63.0%
|
|
Logos Global Management LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,250,000
shares
|
$6.11 Million
0.7% of portfolio
|
Q4 2024
Reduced 54.55%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
1,233,176
shares
|
$6.03 Million
0.0% of portfolio
|
Q4 2024
Added 2372.24%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,170,682
shares
|
$5.72 Million
0.0% of portfolio
|
Q4 2024
Added 22.85%
|
|
Checkpoint Capital L.P.
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,084,135
shares
|
$5.3 Million
2.27% of portfolio
|
Q4 2024
Added 333.65%
|
|
Ally Bridge Group (Ny) LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
781,489
shares
|
$3.82 Million
3.78% of portfolio
|
Q4 2024
Reduced 40.92%
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Feb 14, 2025 Q4 2024 |
771,958
shares
|
$3.77 Million
4.67% of portfolio
|
Q4 2024
Added 165.73%
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
734,234
shares
|
$3.59 Million
0.75% of portfolio
|
Q4 2024
Added 52.15%
|
|
J. Goldman & CO LP
New York, NY |
Feb 14, 2025 Q4 2024 |
537,609
shares
|
$2.63 Million
0.06% of portfolio
|
Q4 2024
Added 261.01%
|